We rank companies based on fund manager, research analyst and news sentiment
FTXH

First Trust Nasdaq Pharmaceuticals ETF
FTXH

$25.82
0.15%
0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

16% more funds holding

Funds holding: 19 [Q3] → 22 (+3) [Q4]

2.13% less ownership

Funds ownership: 49.69% [Q3] → 47.56% (-2.13%) [Q4]

13% less capital invested

Capital invested by funds: $10.2M [Q3] → $8.87M (-$1.29M) [Q4]

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Research analyst outlook

We haven’t received any recent analyst ratings for FTXH.

Financial journalist opinion